Amgen Up on Patent News

Author:
Publish date:

Biotech Amgen (AMGN) - Get Report was up 17.5% on Instinet, after it got word after the close Friday that it won a patent fight against Transkaryotic (TKTX) for its popular anemia treatment, Epogen.